|
시장보고서
상품코드
2119483
췌장루 치료 시장 규모, 점유율, 성장 분석 : 치료 유형별, 의료기기 유형별, 원인별, 최종사용자별, 환자층별, 지역별 - 업계 예측(2026-2033년)Pancreatic Fistula Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Conservative Management, Endoscopic Treatment), By Device Type, By Cause, By End User, By Patient Group, By Region - Industry Forecast 2026-2033 |
||||||
세계의 췌장루 치료 시장 규모는 2024년에 38억 4,000만 달러로 평가되며, 2025년 41억 3,000만 달러에서 2033년까지 74억 3,000만 달러로 확대되어, 예측 기간(2026-2033년) 동안 CAGR 7.6%로 성장할 것으로 전망됩니다.
세계 췌장루 치료 시장은 복부 수술, 특히 암으로 인한 췌두십이지장 절제술의 복잡화를 배경으로 상당한 성장을 이루고 있습니다. 치료법이 기존의 수동적 배액이나 광범위 항생제에서 생분해성 스텐트나 피브린계 실런트와 같은 첨단 솔루션으로 진화함에 따라 회복 기간은 단축되고 재시술률도 감소하고 있습니다. 환자의 최대 30%에 영향을 미치는 수술 후 누공의 유병률은 효과적인 폐쇄 기술의 도입이 시급함을 여실히 보여주고 있습니다. 증거 기반의 진료 관행과 생분해성 피브린 접착제 및 내시경적 유두를 통한 스텐트 삽입을 결합한 혁신적인 기술의 도입은 중환자실(ICU) 입원 기간 단축 및 재입원 비용 절감 등 유망한 결과를 보여주고 있습니다. 이러한 성공은 연구 개발에 대한 투자 확대를 촉진하여 차세대 생체 접착제 개발의 길을 열어주는 동시에 시장 접근성을 넓히고 있습니다.
세계 췌장루 치료 시장의 성장요인
췌장염, 췌장암 및 수술 후 합병증 발생률의 증가로 인해 췌장루에 대한 전문적인 관리가 필요한 환자 수가 증가하고 있으며, 이는 첨단 치료용 의료기기 및 시술에 대한 수요를 견인하고 있습니다. 의료 종사자들은 합병증을 최소화하고, 입원 기간을 단축하며, 환자의 삶의 질을 향상시킬 수 있는 효과적인 해결책을 적극적으로 모색하고 있습니다. 이러한 임상적 요구가 높아짐에 따라 제조사들은 제품 라인업을 확충하고 연구개발에 대한 투자를 촉진하고 있습니다. 또한, 치료되지 않은 누공이 미치는 장기적인 영향에 대한 의료 종사자들의 인식이 높아짐에 따라 조기 개입이 촉진되고 있으며, 그 결과 치료 건수가 증가하여 시장 성장에 기여하고 있습니다.
세계 췌장루 치료 시장의 제약요인
전문 장비 및 영상 진단 기술과 관련된 높은 비용, 그리고 다학제적 협력을 통한 치료팀의 필요성은, 특히 의료 자원이 제한된 지역에서 췌장 누공에 대한 첨단 치료에 대한 접근을 현저히 저해할 가능성이 있습니다. 의료 기관이 예산 제약에 직면할 경우, 고액의 치료법 도입보다는 필수 의료 서비스를 우선시하고, 대신 기존의 관리 전략을 선택하는 경우가 많습니다. 이러한 재정적 부담은 혁신적인 치료법에 대한 투자를 저해할 뿐만 아니라 시장 성장을 제한하고, 전 세계적으로 이 질환으로 고통받는 환자들의 요구를 충분히 충족시키지 못할 가능성이 있는 보수적인 치료법에 의료 종사자들이 의존하게 만드는 결과를 초래하고 있습니다.
세계 췌장루 치료 시장 동향
세계 췌장루 치료 시장에서는 최소침습 기술의 도입을 향한 뚜렷한 추세가 나타나고 있습니다. 이는 회복 기간 단축과 합병증 발생률 감소를 원하는 환자들의 요구에 힘입어 외과 의사들의 선호도가 변화하고 있음을 반영합니다. 첨단 영상 진단 기술 및 전용 기구 등 병원의 기술력 향상으로 인해 내시경 수술이나 경피적 수술과 같은 보다 정밀한 치료가 가능해졌으며, 이러한 방법들은 기존의 개복 수술을 대체할 수 있는 효과적인 대안으로 입증되고 있습니다. 이러한 상황의 변화는 입원 기간 단축으로 이어질 뿐만 아니라 환자의 수술 후 삶의 질도 향상시키고 있으며, 최소침습 치료가 시장의 중요한 성장 요인이 되고 있을 뿐만 아니라 전 세계적으로 보험 적용 범위 확대를 뒷받침하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 췌장루 치료 시장 규모 : 치료 유형별
세계의 췌장루 치료 시장 규모 : 디바이스 유형별
세계의 췌장루 치료 시장 규모 : 원인별
세계의 췌장루 치료 시장 규모 : 최종사용자별
세계의 췌장루 치료 시장 규모 : 환자 그룹별
세계의 췌장루 치료 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.08.28Global Pancreatic Fistula Treatment Market size was valued at USD 3.84 Billion in 2024 and is poised to grow from USD 4.13 Billion in 2025 to USD 7.43 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).
The global market for pancreatic fistula treatment is experiencing significant growth, driven by the increasing complexity of abdominal surgeries, particularly pancreaticoduodenectomies necessitated by cancer. With treatment approaches evolving from traditional passive drainage and broad-spectrum antibiotics to advanced solutions such as biodegradable stents and fibrin-based sealants, recovery times are decreasing, and reintervention rates are lowering. The prevalence of postoperative fistula, affecting up to 30% of patients, underscores the urgency for effective closure technologies. Adoption of evidence-based practices and innovative techniques, like combining biodegradable fibrin glue with endoscopic transpapillary stenting, has shown promising results, including a reduction in ICU stays and readmission costs. This success fosters increased investment in research and development, paving the way for next-generation bio-adhesives and expanding market access.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pancreatic Fistula Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pancreatic Fistula Treatment Market Segments Analysis
Global pancreatic fistula treatment market is segmented by treatment type, device type, cause, end user, patient group and region. Based on treatment type, the market is segmented into conservative management, endoscopic treatment, surgical treatment and interventional radiology. Based on device type, the market is segmented into pancreatic stents, drainage catheters and endoscopic devices. Based on cause, the market is segmented into post-surgical, acute pancreatitis, chronic pancreatitis and trauma. Based on end user, the market is segmented into hospitals, specialty clinics and ambulatory surgical centers. Based on patient group, the market is segmented into adult and pediatric. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pancreatic Fistula Treatment Market
The rising incidence of pancreatitis, pancreatic cancer, and complications following surgery has led to a larger number of patients in need of specialized management for pancreatic fistulas, driving the demand for advanced therapeutic devices and procedures. Healthcare professionals are actively searching for effective solutions that can minimize complications, shorten hospital stays, and enhance patients' quality of life. This increasing clinical demand encourages manufacturers to broaden their product offerings and invest in research and development. Additionally, growing awareness among healthcare providers regarding the long-term repercussions of unmanaged fistulas promotes early intervention, resulting in an uptick in treatment volumes and contributing to market growth.
Restraints in the Global Pancreatic Fistula Treatment Market
The high costs related to specialized equipment, imaging technology, and the need for multidisciplinary care teams can significantly hinder access to advanced treatments for pancreatic fistulas, especially in areas with limited healthcare resources. When medical facilities are faced with budget constraints, they often prioritize essential services over the adoption of expensive treatment options, opting instead for traditional management strategies. This financial strain not only deters investments in innovative therapies but also restricts market growth and encourages healthcare professionals to depend on conservative treatment methods that may not adequately meet the needs of patients suffering from this condition globally.
Market Trends of the Global Pancreatic Fistula Treatment Market
The Global Pancreatic Fistula Treatment market is witnessing a significant trend towards the adoption of minimally invasive techniques, reflecting a shift in surgeon preferences driven by patient demands for faster recovery and lower complication rates. Enhanced technological capabilities in hospitals, including advanced imaging and specialized instruments, are facilitating more precise interventions such as endoscopic and percutaneous procedures, which are proving to be effective alternatives to traditional open surgery. This evolving landscape not only shortens hospital stays but also enhances postoperative quality of life for patients, making minimally invasive options a pivotal growth driver for the market and prompting wider reimbursement frameworks worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Pancreatic Fistula Treatment Market Size by Treatment Type & CAGR (2026-2033)
- Market Overview
- Conservative Management
- Endoscopic Treatment
- Surgical Treatment
- Interventional Radiology
Global Pancreatic Fistula Treatment Market Size by Device Type & CAGR (2026-2033)
- Market Overview
- Pancreatic Stents
- Drainage Catheters
- Endoscopic Devices
Global Pancreatic Fistula Treatment Market Size by Cause & CAGR (2026-2033)
- Market Overview
- Post-Surgical
- Acute Pancreatitis
- Chronic Pancreatitis
- Trauma
Global Pancreatic Fistula Treatment Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Global Pancreatic Fistula Treatment Market Size by Patient Group & CAGR (2026-2033)
- Market Overview
- Adult
- Pediatric
Global Pancreatic Fistula Treatment Market Size & CAGR (2026-2033)
- North America (Treatment Type, Device Type, Cause, End User, Patient Group)
- US
- Canada
- Europe (Treatment Type, Device Type, Cause, End User, Patient Group)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Treatment Type, Device Type, Cause, End User, Patient Group)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Treatment Type, Device Type, Cause, End User, Patient Group)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Treatment Type, Device Type, Cause, End User, Patient Group)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Olympus Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cook Group Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CONMED Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integra LifeSciences Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teleflex Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EndoGI Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intuitive Surgical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Haemonetics Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meril Life Sciences Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
